QTTB Q4 2020 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$980,000+74.1% YoY

Gross Profit

$00.0% margin

Operating Income

-$30M-3041.0% margin

Net Income

-$30M-3039.9% margin

EPS (Diluted)

$-11.15

QoQ Revenue Growth

+72.8%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$264M

Total Liabilities

$68M

Stockholders' Equity

$196M

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$980,000	$563,000	+74.1%
Gross Profit	$0	$0	—
Operating Income	-$30M	-$26M	-16.6%
Net Income	-$30M	-$24M	-23.3%